INTRODUCTION
Chronic peptic ulcers in either the stomach or duodenum may cause scarring and may impair gastric emptying, a condition known as Ôgastric outlet obstructionÕ. In adults, peptic ulcer disease is the major cause of benign gastric outlet obstruction. 1 Most cases are associated with duodenal or pyloric channel ulceration, with gastric ulceration accounting for only 5% of cases. 1 Although the role of Helicobacter pylori infection in non-complicated peptic ulcer disease has been definitively established, the exact relationship between the organism and complicated ulcer disease has not been studied in any detail. The true prevalence of H. pylori infection in ulcer disease complicated by gastric outlet obstruction remains a matter of debate, and the effect of H. pylori eradication on this complication has not been fully established. In this respect, although surgery or balloon dilation has been classically considered to be necessary to relieve the symptoms of gastric outlet obstruction in most patients, more recently resolution of this complication has been reported in patients with peptic ulcers infected by H. pylori after eradication of the organism. Our aim was to review the studies assessing the prevalence of H. pylori infection in patients with gastric outlet obstruction, and to evaluate the effect of eradication of the infection on the resolution of this important complication. Bibliographical searches were performed in the PubMed (Internet) database, including studies available until October 2001, looking for the following words (all fields): (Helicobacter pylori OR H. pylori) and (obstruction OR stenosis OR gastric outlet obstruction). References from reviews on gastric outlet obstruction in peptic ulcer disease, and from the articles selected for the study, were also examined in search of articles meeting the inclusion criteria. Articles published in any language were included. The prevalence of H. pylori infection in patients with gastric outlet obstruction in each study was recorded, and the diagnostic methods used to detect the organism were also identified. The weighted mean (taking into account the number of patients in each study) of prevalence and the 95% confidence interval were calculated. The effect of eradication of the infection on the resolution of gastric outlet obstruction was assessed in all studies.
PREVALENCE OF H. PYLORI INFECTION IN GASTRIC OUTLET OBSTRUCTION
The prevalence of H. pylori infection in non-complicated peptic ulcer disease has been reported to be very high, especially if patients taking non-steroidal anti-inflammatory drugs (NSAIDs) are excluded. 2, 3 However, the prevalence of the organism in complicated ulcer disease, and specifically in those patients with gastric outlet obstruction, has not been assessed in detail, although it appears to be lower than that in uncomplicated ulcer disease. 4 Some authors have reported quite a low prevalence of H. pylori infection in gastric outlet obstruction, with values ranging from 33% to 69%.
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These results suggest, as has been proposed in the case of perforation, 10 that ulcer disease complicated by obstruction has a different pathogenesis from chronic peptic ulcer disease, and that the first should not be regarded simply as a complication of the second. In the study with the lowest prevalence of H. pylori, 5 the presence of the infection was examined in patients undergoing resection for gastric outlet obstruction. The organism was detected in only 33% of cases using Steiner stain from either pre-operative endoscopic biopsy or, in most patients, final surgical specimens. This low prevalence could be explained, at least in part, by the use of only one diagnostic method to detect consecutive patients presenting with clinically and endoscopically significant gastric outlet obstruction.
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During each endoscopy, seven gastric biopsy specimens were obtained (from the antrum, corpus and fundus) and analysed for H. pylori colonization by both rapid urease test and histological methods. The antral mucosal biopsy specimens were positive for H. pylori in nine patients, that is, in 90% of patients. The use of more than one diagnostic method and the high number of biopsies taken could explain the high prevalence of the infection reported in this study. In summary, from the seven studies shown in Table 1 , including 187 patients with gastric outlet obstruction, an overall H. pylori infection rate (weighted mean) of 69% is calculated (95% confidence interval, 62-76%), a value that is, effectively, relatively low. Although prevalence studies are interesting, casecontrol studies comparing patients with gastric outlet obstruction with those with non-complicated ulcer disease provide more information. In this respect, Kate Gibson et al. 5 
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RUT, H, S 91 H, histology; RUT, rapid urease test; S, serology. Overall H. pylori infection rate (weighted mean) ¼ 69% (95% confidence interval, 62-76%).
et al. included 103 patients in their study: 37 had duodenal ulcer (Group I), 35 duodenal ulcer disease with gastric outlet obstruction with the presence of an active ulcer in the duodenum (Group II), and 31 duodenal ulcer disease with gastric outlet obstruction but no active ulcer (Group III). 12 The presence of H. pylori infection was determined by urease test, serology and ⁄ or histology. The prevalence of H. pylori infection in the three groups was not significantly different (95%, 91% and 90%, respectively). The conclusion of this study was that the prevalence of H. pylori infection was high in patients with duodenal ulcer and was unaltered by the presence of gastric outlet obstruction.
ROLE OF ANTIMICROBIAL TREATMENT IN GASTRIC OUTLET OBSTRUCTION
The standard treatment for benign, non-resolving gastric outlet obstruction is either endoscopic balloon dilation or surgery. 13 More recently, the resolution of gastric outlet obstruction after the eradication of H. pylori has been described in several studies, summarized below. de Boer & Driessen reported the first case of the resolution of gastric outlet obstruction after the eradication of H. pylori. 14, 15 In the same year, Annibale et al. reported the case of a patient with duodenal bulb stenosis and active ulcer in whom 4 months of omeprazole (40 mg ⁄ day) had not modified the endoscopic picture. 16 The diagnosis of H. pylori infection and its treatment led to the cure of both duodenal ulcer and bulbar stenosis. This case illustrates that H. pylori eradication is able to cure refractory duodenal ulcer and stenosis which have not responded to previous treatment with potent antisecretors, such as proton pump inhibitors. In 1996, Tursi et al. prescribed H. pylori eradication therapy to two patients with duodenal and pyloric stenosis, and reported the resolution of both the symptoms and the endoscopic lesions. 17 One year later, Lam et al. treated nine patients with H. pylori-positive benign gastric outlet obstruction with triple therapy (bismuth, tetracycline and metronidazole) for 1 week without acid suppression. 7 Six patients also underwent incremental endoscopic balloon dilation. All of the six patients treated by endoscopic balloon dilation and H. pylori eradication remained symptom free for a median follow-up of 16.5 months. In contrast, outcomes for H. pylori-negative patients, whether treated with dilation or long-term acid suppression, were much less favourable.
In 1998, Malik et al. studied six patients with duodenal ulcer-related gastric outlet obstruction positive for H. pylori, and treated them with eradication therapy. 18 Repeated endoscopic follow-ups revealed a significant dilation and clinical improvement in all patients, and none required surgery. In the same year, Díaz Blasco & García Valriberas reported the case of one patient with pyloric stenosis and secondary gastric outlet obstruction in whom H. pylori was treated, with clinical improvement of the patient. 19 Misra et al. reported a patient in whom endoscopic examination revealed findings suggestive of gastric outlet obstruction with nodularity of the antral mucosa leading to deformity of the pylorus. The time-span from H. pylori eradication to gastric outlet obstruction resolution represents a relevant aspect of this type of treatment. Brandimarte et al. studied 22 patients with benign peptic stenosis and H. pylori infection who were treated with anti-H. pylori therapy, with endoscopic controls after the end of therapy, at 2 and 6 months, and then every 6 months. 22 Peptic stenosis disappeared completely in 20 of the 22 cases (17 ⁄ 20 after 2 months and 3 ⁄ 20 after 6 months) after H. pylori eradication, and in all of these patients the symptoms disappeared within 2 months. These data are similar to those reported by Taskin et al., where the resolution of gastric outlet obstruction with eradication therapy was maximal at the end of the first month of treatment. 11 Therefore, it seems that the beneficial effect of H. pylori eradication on gastric outlet obstruction is observed early, just a few weeks after the administration of antimicrobial treatment.
The long-term duration of the beneficial effects of H. pylori eradication, after the initial disappearance of the microorganism, is unknown. In one study, at a median follow-up of 12.4 months after H. pylori eradication therapy, the patients remained asymptomatic, without recurrence of stenosis, and required no medication. 22 This observation suggests that the favourable effect of H. pylori eradication -that is, the resolution of gastric outlet obstruction -remains for at least 1 year. The question may be raised as to whether gastric outlet obstruction always resolves after H. pylori eradication treatment and, if not, what is the explanation for the negative response. Boylan & Gradzka reviewed a series of patients treated with balloon dilation and assessed the factors that affected the success rate. 9 The eradication of H. pylori in nine patients was associated with the successful relief of obstruction without surgery. Only one case in this group of H. pylori-eradicated patients required surgery, and this patient was found to be a surreptitious NSAID user. Thus, NSAID intake should be excluded in cases with ulcer disease complicated by gastric outlet obstruction, and also in previously infected patients that do not respond or recur (especially after balloon dilation).
In another study, although the resolution of gastric outlet obstruction was generally observed, stenosis did not disappear in one patient despite H. pylori eradication and continuous proton pump inhibitor treatment. 22 Furthermore, other authors have reported experience against an important role of antimicrobial treatment in gastric outlet obstruction. 5, [23] [24] [25] Thus, Gibson et al.
prescribed eradication therapy alone (without endoscopic balloon dilation) to three H. pylori-positive patients with gastric outlet obstruction, this regimen being unsuccessful in avoiding operation. 5 In this same study, it was suggested that patients negative for H. pylori responded poorly to pneumatic dilation, suggesting that they should be strongly considered for an early, definitive, acid-reducing surgical procedure. Rinaldi et al. reported the case of a patient who had two active ulcers with duodenal stenosis. 23, 24 After H. pylori eradication, the ulcer healed, although central duodenal bulb stenosis, caused by fibrotic scarring, persisted. The authors concluded that fibrotic scarring may not regress after H. pylori eradication. However, as pointed out by de Boer, 26 after close examination of the report by Rinaldi et al., 23 it becomes evident that they actually report the successful medical treatment of duodenal stenosis. Their patient presented with pain and vomiting and was found to have active ulcers with stenosis of a deformed bulb. After diagnostic endoscopy, they prescribed H. pylori eradication treatment and thereafter the patient became completely symptom free. Similarly, De Francesco et al. presented the cases of two patients with endoscopically confirmed duodenal stenosis, caused by an active duodenal ulcer, and concomitant H. pylori infection. 25 After the eradication of the organism, the radiographic study confirmed duodenal ulcer healing, but duodenal stenosis persisted unmodified. Nevertheless, both patients demonstrated relief from their symptoms. Thus, even though an anatomic stenosis identified only by endoscopy persisted, functional stenosis was no longer present (and, after 4 months, further endoscopic examination showed that the duodenal stenosis was still stable). These observations suggest that the main clinical issue is the patient's symptoms and not the width of the pyloric opening itself. 26 It has been suggested that, in active duodenal ulcer, it is possible to identify two successive steps: duodenal ulcer activity, characterized by oedema and duodenospasm; and duodenal ulcer healing, characterized by collagen synthesis and fibrosis. Thus, gastric outlet obstruction may occur because of two underlying mechanisms. First, an acute ulcer can produce sufficient inflammation and oedema and ⁄ or muscular spasm to obstruct the lumen. Second, chronic scarring associated with fibrosis may cause narrowing and subsequent pyloric channel or duodenal obstruction. The supporters of H. pylori eradication as therapy for benign gastric outlet obstruction suggest that, because H. pylori infection causes severe inflammation with impressive oedema, the gastric outlet obstruction is provoked more by oedema than by fibrosis, and H. pylori eradication reduces oedema and permits resolution of the gastric outlet obstruction. 21 Nevertheless, Borody et al. believe that even tight stricturing and (presumably) associated fibrosis may be reversible. 27 They postulated that the resolution of associated luminal oedema following H. pylori eradication allowed early improvement in gastric emptying and symptoms. 27 One could, however, speculate that such an approach might only be useful in the subset of patients with benign gastric outlet obstruction and an acute, oedematous ulcer, as opposed to the situation in patients who present with a non-ulcerated, fibrotic stricture (after having been afflicted with recurrent ulcers over many years), in whom antimicrobial therapy alone would not be sufficient to resolve the problem. 6, 28 Nevertheless, although fibrosis may be an irreversible (or at best only partially reversible) phenomenon, H. pylori eradication is followed by duodenal ulcer healing and decreases in oedema and spasm, which may explain the symptomatic improvement even in (presumably) fibrotic stenosis. Furthermore, some studies have demonstrated that the ÔfibroticÕ pylorus may open up over time, 26, 27 thus suggesting that a few months of follow-up might not have allowed some authors to witness this. In this context, some authors have proposed that endoscopic balloon dilation could be used first to dilate the fibrous stricture, followed by anti-H. pylori therapy to prevent re-ulceration and re-stenosis. these patients have ulcer disease, they therefore need eradication therapy, and the aforementioned results suggest that it is best given right from the start. It is unknown whether maintenance treatment with antisecretory drugs is necessary after H. pylori eradication has been achieved and gastric outlet obstruction resolved. In a recent study, Taskin et al. administered H. pylori eradication therapy to 10 patients presenting with gastric outlet obstruction. 11 The infection was eradicated and complete ulcer healing was observed in all patients. Nevertheless, one patient had duodenal perforation and underwent surgical intervention following medical treatment, despite the eradication of H. pylori. Furthermore, ulcer recurrence was noted in two of the other nine patients, and in one the recurrent ulcer was complicated by obstruction. Because H. pylori could not be detected at the time of ulcer recurrence, it could not be attributed to H. pylori re-infection or recrudescence. Thus, some authors have suggested that the long-term use of acid suppression despite H. pylori eradication in ulcer disease complicated by gastric outlet obstruction may be justified. It is clear that further studies with a higher number of patients and longer follow-up are necessary to conclude whether the H. pylori eradication regimen should be followed by antisecretory maintenance treatment in all cases.
CONCLUSIONS
The prevalence of H. pylori infection in peptic ulcer disease complicated by gastric outlet obstruction seems to be, overall, lower than that reported in noncomplicated ulcer disease, with a mean value of 69%. However, H. pylori infection rates in various studies range from 33% to 91%, suggesting that differences in variables, such as the number and type of diagnostic methods used or the frequency of NSAID intake, may be responsible for the low prevalence reported in some studies. The resolution of gastric outlet obstruction after the eradication of H. pylori has been demonstrated by several studies. It seems that the beneficial effect of H. pylori eradication on gastric outlet obstruction is observed early, just a few weeks after the administration of antimicrobial treatment. Furthermore, this favourable effect seems to remain in long-term follow-up. Nevertheless, gastric outlet obstruction does not always resolve after H. pylori eradication treatment, and the explanation for the failures is not completely clear, NSAID intake perhaps playing a major role in these cases. Treatment should start pharmacologically with the eradication of H. pylori even when stenosis is considered to be fibrotic or when there is some gastric stasis. In summary, H. pylori eradication therapy should be considered the first step in the treatment of duodenal or pyloric H. pylori-positive stenosis, whereas dilation or surgery should be reserved for patients who do not respond to such medical therapy.
